Paper36943605
Harmaline exerts potentially anti-cancer effects on U-87 human malignant glioblastoma cells in vitro.
Vahedi MM and 8 others. Mol Biol Rep, 2023. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Harmaline exerts potentially anti-cancer effects on U-87 human malignant glioblastoma cells in vitro. Papers, record 36943605. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36943605
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Harmaline exerts potentially anti-cancer effects on U-87 human malignant glioblastoma cells in vitro.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Glioblastoma | Major topic |
| Humans | |
| Harmaline | |
| Cell Line, Tumor | |
| Reactive Oxygen Species | |
| Apoptosis | |
| Cell Proliferation |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Mashhad University of Medical Sciences | Mashhad University of Medical Sciences | PubMed |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35997850 | Thymol has anticancer effects in U-87 human malignant glioblastoma cells. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/35997850 | PubMed |
| 2 | 29510157 | Demethoxycurcumin mediated targeting of MnSOD leading to activation of apoptotic pathway and inhibition of Akt/NF-κB survival signalling in human glioma U87 MG cells. | Toxicol Appl Pharmacol | 2018 | https://conductscience.org/library/papers/29510157 | PubMed |
| 3 | 8015608 | A matrix metalloproteinase expressed on the surface of invasive tumour cells. | Nature | 1994 | https://conductscience.org/library/papers/8015608 | PubMed |
| 4 | 35327366 | Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma. | Biomedicines | 2022 | https://conductscience.org/library/papers/35327366 | PubMed |
| 5 | 17703736 | A study on the antitumoral and differentiation effects of peganum harmala derivatives in combination with ATRA on leukaemic cells. | Arch Pharm Res | 2007 | https://conductscience.org/library/papers/17703736 | PubMed |
| 6 | 18523842 | Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities. | J Nat Med | 2008 | https://conductscience.org/library/papers/18523842 | PubMed |
| 7 | 32767939 | Modulation of Calcium Signaling in Glioblastoma Multiforme: A Therapeutic Promise for Natural Products. | Mini Rev Med Chem | 2020 | https://conductscience.org/library/papers/32767939 | PubMed |
| 8 | 34545650 | Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting mTOR. | Phytother Res | 2021 | https://conductscience.org/library/papers/34545650 | PubMed |
| 9 | 18212366 | Peganum harmala can minimize Escherichia coli infection in poultry, but long-term feeding may induce side effects. | Poult Sci | 2008 | https://conductscience.org/library/papers/18212366 | PubMed |
| 10 | 23707188 | Recent pharmacological developments in β-carboline alkaloid "harmaline". | Eur J Pharmacol | 2013 | https://conductscience.org/library/papers/23707188 | PubMed |
| 11 | 20946891 | Recent advances in the study on capsaicinoids and capsinoids. | Eur J Pharmacol | 2011 | https://conductscience.org/library/papers/20946891 | PubMed |
| 12 | 26678950 | Novel mechanism of harmaline on inducing G2/M cell cycle arrest and apoptosis by up-regulating Fas/FasL in SGC-7901 cells. | Sci Rep | 2015 | https://conductscience.org/library/papers/26678950 | PubMed |
| 13 | 27646922 | Activation of apoptosis signalling pathways by reactive oxygen species. | Biochim Biophys Acta | 2016 | https://conductscience.org/library/papers/27646922 | PubMed |
| 14 | 7560408 | Response of L-929 fibroblasts, human gingival fibroblasts, and human tissue mast cells to various metal cations. | J Dent Res | 1995 | https://conductscience.org/library/papers/7560408 | PubMed |
| 15 | 29755345 | Analogous β-Carboline Alkaloids Harmaline and Harmine Ameliorate Scopolamine-Induced Cognition Dysfunction by Attenuating Acetylcholinesterase Activity, Oxidative Stress, and Inflammation in Mice. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29755345 | PubMed |
| 16 | 35963316 | Harmaline downregulates angiogenesis markers and suppresses the growth of 4T1 breast cancer cells in vivo and in vitro. | Chem Biol Interact | 2022 | https://conductscience.org/library/papers/35963316 | PubMed |
| 17 | 31880372 | Quercetin: A promising phytochemical for the treatment of glioblastoma multiforme. | Biofactors | 2020 | https://conductscience.org/library/papers/31880372 | PubMed |
| 18 | 19440234 | p21 in cancer: intricate networks and multiple activities. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19440234 | PubMed |
| 19 | 33932560 | Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. | Biochim Biophys Acta Rev Cancer | 2021 | https://conductscience.org/library/papers/33932560 | PubMed |
| 20 | 29434892 | Effects of harmaline on cell growth of human liver cancer through the p53/p21 and Fas/FasL signaling pathways. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29434892 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42643551 | Effectiveness of harmaline along with meglumine antimoniate on Leishmania major. | Vet Res Forum | 2026 | https://conductscience.org/library/papers/42643551 | PubMed |
| 42640499 | The potential of harmaline on triple negative breast cancer: harmaline-DNA interaction related apoptosis, anti-metastasis, and in silico analysis. | Histochem Cell Biol | 2026 | https://conductscience.org/library/papers/42640499 | PubMed |
| 41645031 | Synthesis and in Silico Evaluation of Novel Triazolone-Derived Naphthalene-2-Sulfonates, Evaluation of Potential Antiproliferative Agents and Enzyme Inhibitory Activities. | Biotechnol Appl Biochem | 2026 | https://conductscience.org/library/papers/41645031 | PubMed |
| 41509117 | Synergistic effects of oxypeucedanin and temozolomide on viability, proliferation, apoptosis, and migration of T98G malignant glioblastoma cells. | Avicenna J Phytomed | 2025 | https://conductscience.org/library/papers/41509117 | PubMed |
| 40286187 | Plant Alkaloids as Promising Anticancer Compounds with Blood-Brain Barrier Penetration in the Treatment of Glioblastoma: In Vitro and In Vivo Models. | Molecules | 2025 | https://conductscience.org/library/papers/40286187 | PubMed |
| 39927019 | Anticancer and Antioxidant Activities of Methanolic Extract of Ziziphus Spina-Christi Leaves against Human Gastric Carcinoma Cells. | J Pharm Bioallied Sci | 2024 | https://conductscience.org/library/papers/39927019 | PubMed |
| 39770065 | Cationic Micelle-like Nanoparticles as the Carrier of Methotrexate for Glioblastoma Treatment. | Molecules | 2024 | https://conductscience.org/library/papers/39770065 | PubMed |
| 39698882 | Metabolomics and Anticancer Potential of the Aerial Parts of Dryopteris ramosa against Cancerous Cell Lines Assisted with Advanced Computational Approaches. | Curr Pharm Des | 2025 | https://conductscience.org/library/papers/39698882 | PubMed |
| 38931386 | The Role of Ayahuasca in Colorectal Adenocarcinoma Cell Survival, Proliferation and Oxidative Stress. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38931386 | PubMed |
| 38872006 | Cytotoxicity of alkaloids isolated from Peganum harmala seeds on HCT116 human colon cancer cells. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38872006 | PubMed |
| 38790017 | Repurposing harmaline as a novel approach to reverse tmexCD1-toprJ1-mediated tigecycline resistance against klebsiella pneumoniae infections. | Microb Cell Fact | 2024 | https://conductscience.org/library/papers/38790017 | PubMed |
| 37896127 | Nedaplatin/Peganum harmala Alkaloids Co-Loaded Electrospun, Implantable Nanofibers: A Chemopreventive Nano-Delivery System for Treating and Preventing Breast Cancer Recurrence after Tumorectomy. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37896127 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| H3P16 | 644914 | PubTator's text mining | https://conductscience.org/library/genes/644914 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36943605
GET https://conductscience.org/api/papers/v1/36943605/references?page=2